Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Approves Non-Cariogenic Health Claim for Isomaltulose - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

FDA Approves Non-Cariogenic Health Claim for Isomaltulose

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

FDA has authorized a non-cariogenic health claim for the carbohydrate sweetener isomaltulose. This official categorization in the U.S. helps clear the way to new opportunities in positioning and product claims for food and beverage manufacturers. “Cariogenic” describes a substance that stimulates tooth decay (dental caries). It is a common description for sugars that can easily be digested by oral bacteria, such as sucrose, fructose (including HFCS-high fructose corn syrup) and lactose. Though produced from real sugar and exhibiting a very natural taste profile, isomaltulose is distinguished by a very strong molecular binding, which cannot be broken by plaque bacteria and prevents the generation of acids that harm tooth enamel. In contrast with easily degradable carbohydrates, there is no formation of caries with isomaltulose. Isomaltulose has successfully passed the thorough FDA approval procedure and is now officially categorized as “non-cariogenic” in the U.S. Both Cargill, Minneapolis, MN, and Germany-based Palatinit offer forms of isomaltulose under the brand names Xtend and Palatinose, respectively.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters